JP2004533434A5 - - Google Patents

Download PDF

Info

Publication number
JP2004533434A5
JP2004533434A5 JP2002584700A JP2002584700A JP2004533434A5 JP 2004533434 A5 JP2004533434 A5 JP 2004533434A5 JP 2002584700 A JP2002584700 A JP 2002584700A JP 2002584700 A JP2002584700 A JP 2002584700A JP 2004533434 A5 JP2004533434 A5 JP 2004533434A5
Authority
JP
Japan
Prior art keywords
therapeutic agent
tegafur
uracil
dose
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002584700A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004533434A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/012769 external-priority patent/WO2002087335A1/en
Publication of JP2004533434A publication Critical patent/JP2004533434A/ja
Publication of JP2004533434A5 publication Critical patent/JP2004533434A5/ja
Withdrawn legal-status Critical Current

Links

JP2002584700A 2001-04-26 2002-04-22 テガフール、ウラシル、フォリン酸およびシクロホスファミドの投与による腫瘍の治療方法 Withdrawn JP2004533434A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28672901P 2001-04-26 2001-04-26
PCT/US2002/012769 WO2002087335A1 (en) 2001-04-26 2002-04-22 Method for treating tumors by the administration of tegafur, uracil, folinic acid, and cyclophosphamide

Publications (2)

Publication Number Publication Date
JP2004533434A JP2004533434A (ja) 2004-11-04
JP2004533434A5 true JP2004533434A5 (https=) 2005-12-22

Family

ID=23099905

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002584700A Withdrawn JP2004533434A (ja) 2001-04-26 2002-04-22 テガフール、ウラシル、フォリン酸およびシクロホスファミドの投与による腫瘍の治療方法

Country Status (10)

Country Link
US (1) US6620816B2 (https=)
EP (1) EP1399021A1 (https=)
JP (1) JP2004533434A (https=)
CA (1) CA2445262A1 (https=)
CZ (1) CZ20032835A3 (https=)
HU (1) HUP0303953A3 (https=)
MX (1) MXPA03009681A (https=)
NO (1) NO20034690L (https=)
PL (1) PL373247A1 (https=)
WO (1) WO2002087335A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1798689B1 (en) * 2001-06-26 2008-12-03 Sony Corporation Image processing apparatus and method, and image-capturing apparatus
JP4596220B2 (ja) 2001-06-26 2010-12-08 ソニー株式会社 画像処理装置および方法、記録媒体、並びにプログラム
US7951780B2 (en) * 2004-02-25 2011-05-31 Astellas Pharma Inc. Antitumor agent
JP2006160664A (ja) * 2004-12-07 2006-06-22 Vitamin C60 Bioresearch Kk フリーラジカル疾患予防治療用組成物
CN101657203B (zh) * 2007-03-02 2012-09-05 卧龙岗大学 抗癌药的组合物及递送方法
US20160067182A1 (en) * 2013-04-09 2016-03-10 Merrimack Pharmaceuticals, Inc. Methods and compositions for improving outcomes of liposomal chemotherapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328229A (en) 1978-03-29 1982-05-04 Taiho Pharmaceutical Company Limited Anti-cancer composition for delivering 5-fluorouracil to cancer tissues
US5534513A (en) * 1991-09-05 1996-07-09 Taiho Pharmaceutical Company, Ltd. Antitumor potentiator and antitumor composition
US5688773A (en) * 1994-08-17 1997-11-18 The General Hospital Corporation Method of selectively destroying neoplastic cells

Similar Documents

Publication Publication Date Title
JP2005525345A5 (https=)
JP2006523216A5 (https=)
JP2019503365A5 (https=)
JP2005515966A5 (https=)
ATE526950T1 (de) Hydrocodon-formulierungen mit gesteuerter freisetzung
AP2001002288A0 (en) Methods for treatment of sickle cell anemia.
WO2004043389B1 (en) Methods of treating cancer and related methods
RU2003129527A (ru) Способ и дозированная форма для опухолей путем введения тегафура, урацила, фолиновой кислоты, паклитаксела и карбоплатины
IL158668A0 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
CA2468314A1 (en) The use of water-soluble lamarin in the treatment of cancer
JPS59193821A (ja) 抗不安薬としてのフルオキセチンの使用法
JPH10147529A5 (https=)
JP2004533434A5 (https=)
JP2002540148A5 (https=)
JP2002326936A5 (https=)
JP2021503448A5 (https=)
US6620816B2 (en) Method for treating tumors by the administration of tegafur, uracil, folinic acid, and cyclophosphamide
RU2004112422A (ru) Роувастатин в преддеменционных состояниях
JP2005502690A5 (https=)
TNSN06003A1 (en) Saquinavir mesylate oral dosage form
RU97112236A (ru) Способ лечения злокачественных опухолей кости и метастазов в кость остеолитического характера
JP2003523385A5 (https=)
JP2005509663A5 (https=)
CA2576926A1 (en) Use of midostaurin for treating gastrointestinal stromal tumors
RU2002104753A (ru) Способ профилактики и лечения лейкоза крупного рогатого скота